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Abstract 
 
 Alzheimer's disease (AD) is characterized by progressive cognitive impairment associated 
with marked cholinergic neuron loss and amyloid-β (Aβ) peptide accumulation in the brain. The 
cytotoxicity in AD is mediated, at least in part, by Aβ binding with the extracellular domain of the 
p75 neurotrophin receptor (p75NTR), localized predominantly in the membranes of 
acetylcholine-producing neurons in the basal forebrain. Hypothesizing that an open unstructured 
loop of p75NTR might be the effective site for Aβ binding, we have immunized both olfactory 
bulbectomized (OBX) and sham-operated (SO) mice (n = 82 and 49, respectively) with synthetic 
peptides, structurally similar to different parts of the loops, aiming to block them by specific 
antibodies. OBX-mice have been shown in previous studies, and confirmed in the present one, 
to be characterized by typical behavioral, morphological and biochemical AD hallmarks, 
including cholinergic deficits in forebrain neurons. Immunization of OBX- or SO-mice with KLH 
conjugated fragments of p75NTR induced high titers of specific serum antibodies for each of 
nine chosen fragments. However, maximal protective effects on spatial memory, evaluated in a 
Morris water maze, and on activity of choline acetyltransferase in forebrain neurons, detected by 
immunoreactivity to specific antibodies, were revealed only for peptides with amino acid residue 
sequences of 155-164 and 167-176. We conclude that the approach based on immunological 
blockade of specific p75NTR sites, linked with the cytotoxicity, is a useful and effective tool for 
study of AD-associated mechanisms and for development of highly selective therapy of 
cholinergic malfunctioning in AD patients. 
 
Keywords: cholinergic mediation; acetyltransferase, olfactory bulbectomy; spatial memory; 
amyloid-beta; Morris water maze 
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1. Introduction 
 
 The basal forebrain cholinergic neurons, innervating the cerebral cortex and hippocampus, 
are involved in learning/memory functions, and their loss is associated with impairment of 
cognition in Alzheimer's disease (AD) in particular [1]. AD progression has been shown to be 
characterized by the attenuating activity of choline acetyltransferase (ChAT), an acetylcholine-
synthesizing enzyme [2]. However, at preclinical stages of AD, ChAT activity was unaffected, 
which is supposed to be associated with involvement of cholinergic compensatory plasticity [3]. 
These findings suggest that a potential treatment for AD should be targeted at an early stage of 
the disease progression [4]. The most suitable model directly associated with AD progression is 
that of animals with surgically removed olfactory bulbs (OBX) that showed both typical 
behavioral, morphological and biochemical AD hallmarks [5] and phasic time courses in their 
expression after the bulbectomy [6]. One of potential targets thought to be critically involved in 
the pathogenesis of AD, a neurotrophin cell surface receptor (NTR), p75NTR [7], has been 
shown to bind with amyloid-β (Aβ) peptides [8] that, in turn, promotes Aβ-associated neuronal 
dystrophy [9], and regulates both Aβ levels [10], [11], neuronal death [12], and cholinergic 
transmission [13]. Furthermore, in the AD brain, p75NTR expression is enhanced both in 
forebrain neurons and in their terminals in the cortex and hippocampus [14], [15]. Interestingly, 
the Aβ-induced neurotoxicity has been noted to be attenuated in these brain areas whereas the 
loss of cholinergic neurons in the basal forebrain to be increased [16]. The multifunctional 
characteristics of p75NTRs seem to be associated with the capability of Aβ-p75NTR complexes 
to activate a number of extra- and intra-cellular signaling pathways [17], implementing selectivity 
of Aβ-produced neurotoxicity toward cholinergic basal forebrain neurons in particular [18], [19]. 
Within the intracellular structures activated through extracellular domain of p75NTR, a death 
receptor (DR6) is associated with Aβ-induced apoptosis [7], and its blockade by specific 
antibodies (“intrabodies”) has been shown to attenuate Aβ-induced caspase 3 activation 
mediated by DR6 and resulting in cell death through the Jun kinase (JNK) pathway [20]. The 
neurotrophin binding with the extracellular domain of p75NTR may promote neuronal survival as 
well, either through the nuclear factor-κB (NF-κB) pathway or via p75NTR crosstalk with an 
"anti-apoptotic" tropomyosin related kinase (Trk) receptor [21]. The expression of Trk subtype 
NTR has been shown to be decreased in basal forebrain cholinergic neurons in AD [22]. 
Nevertheless, conformational transformations, revealed after neurotrophin binding with p75NTR 
and favorable to simultaneous binding of Trk and p75NTR monomers with the same 
neurotrophin dimer [23], might be a reasonable basis for development of a potentially effective 
approach to treat the AD-associated cholinergic malfunctioning. Indeed, the cysteine-rich (CR1-
4) repeats of the p75NTR extracellular domain have been shown to have several binding sites 
for neurotrophins and amyloid-β [24], [7]. Therefore, we suggest that the open unstructured 
loops in this domain contain the sites for binding with ligands and are the most accessible 
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targets for immunological treatment. Recently, an antibody against the extracellular domain of 
p75NTR has been shown to inhibit, partially, Aβ1–42-induced cell death in hippocampal neuronal 
cultures in vitro [18]. To unmask in vivo the p75NTR site(s) specifically linked with loss of ChAT-
containing forebrain neurons typical for AD we immunized OBX-mice with synthetic peptides, 
analogs of different p75NTR fragments of these loops. In addition, they were characterized by 
relatively high homology of their primary amino acid structures in mouse and human. To 
evaluate the efficacy of the treatment in OBX-mice the extents both of spatial memory 
improvement in a Morris water maze and recovery of ChAT-positive cell density in the basal 
forebrain were analyzed. Recently, this immunological approach has allowed the revealing of 
the Aβ-binding sites on α7-nicotinic acetylcholine and prion receptors whose blockade with 
specific antibodies suppressed the progression of AD-linked neurodegeneration in OBX mice 
[25], [26]. 
 In our present study with nine selected amino acid fragments of p75NTR, only immunization 
against two of sequences 155-164 and 167-176 effectively protected cholinergic mediation in 
the forebrain and, as a result, cognitive abilities of OBX-mice from AD-like neurodegeneration.  
 
2. Material and methods 
 
 One hundred and thirty one male mice (NMRI, Charles River, USA) bred in a colony under 
controlled barrier conditions were used in this study. The animals were given food and water ad 
libitum and reared in a standard 12-h/12-h day/night cycle. The procedures were carried out in 
accord with the principles enunciated in the Guide for Care and Use of Laboratory Animals, NIH 
publication No 85-23, and approved by the Institutional Ethical Review Committee. 
 
2.1 Olfactory bulbectomy (OBX) 
 Nearly three-month old mice (25-30 g) were anaesthetized with Nembutal (40 mg/kg, i.p.) 
and a hole of 2 mm in diameter was drilled medially over the olfactory bulbs (2.0 mm anterior to 
bregma). The bulbs were aspirated carefully under visual control through a blunt needle 
attached to a water pump. Sham-operated mice were treated similarly with exception of the 
bulbectomy. 
 
2.2 Experimental protocol 
 The first immunization procedure (Day 1) initiating production of antibodies against one of 
nine selected p75NTR fragments (32-46, 39-47, 66-72, 86-93, 97-105, 115-122, 147-154, 155-
164, and 167-176) was performed on two-month old mice, which were then bulbectomized or 
sham-operated on Day 25 and immunized repeatedly on Day 43. For the immunization, 
emulsions of PBS solution of a KLH-peptide conjugate (Sigma-Aldrich, USA) mixed with either 
CFA or IFA (the 1st or the 2nd immunization, respectively; Disco laboratories, USA) were 
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subcutaneously (s.c.) injected at a dose of 100 µg of the protein per mouse in the proximal part 
of its tail (in control groups, vehicle was used). Starting on Day 53 mice were trained in a Morris 
water maze: initially, in 3 trials, to reach a visible saving platform and then, in 4 daily trials for 5 
days, with an invisible (submerged) platform. Finally, on Day 58, a memory test followed by the 
brain preparation for further histological and histoimmunochemical analysis was performed. The 
serum samples for the antibody titer estimation were taken from the eye vein on Day 52 and 
kept at -20oC for further analysis (see results in Table 1). As controls for the p75NTR fragments, 
KLH (Keyhole Limpet Hemocyanin) conjugate of SQDRHKQKIIAPAKQLL peptide 
corresponding to the fragment of 197-213 of VP1 protein from foot-and-mouth disease virus 
(VP1), and KLH along were used. The Maxisorp’s 96-wells plates (Nunc, Denmark) were coated 
with 20 µg/ml ovalbumin-conjugated peptide in 0.05 M sodium bicarbonate buffer (pH 9.5); 
blood serum samples in successive twofold dilutions were added. Then the incubation with anti-
mouse immunoglobulin antibodies conjugated to horseradish peroxidase was carried out. The 
substrate solution (0.05% hydrogen peroxide and 0.05% o-phenylenediamine in citrate buffer, 
pH 5.0) was added to the wells for visualization. The reaction was stopped by adding 10% 
sulfuric acid, and optical absorption was measured at 492 nm. The highest dilution of the sera 
with OD>0.1, which was still positive and exceeded the level of preimmune serum more than 
twofold, was taken as the antibody titer.  
 
2.3 Spatial discrimination testing (Morris water maze) 
 On the 28th day after surgery (Day 53 after 1-st immunization), the learning/memory abilities 
of the mice were tested with the Morris water maze in a circular water pool (90 cm in diameter, 
50 cm in height), filled to a depth of 40 cm with water (33oC±1) rendered opaque by the addition 
of powdered milk. Four equal virtual sectors in the pool were arbitrary indicated as I, II, III, and 
IV. Each mouse was first tested on its capability to reach a visible platform (0.5 cm above the 
water surface, 8 cm in diameter). All mice used in this study demonstrated similar swimming 
abilities in reaching the visible platform. A day later and for 5 days, each mouse was trained (4 
trials per day, with an intertrial interval of 25-30 min) to find the platform centered in sector III but 
submerged 0.5 cm below the surface. The animals were placed in a randomly chosen sector 
and allowed a maximum of one minute to find the platform followed by a 15-sec rest period, 
once on the platform, before being dried and relocated into the home cage. An unsuccessful 
mouse was gently redirected to the platform after exceeding the 60-sec limit. On the day after 
the end of the training trials, a 60-sec memory test, with the platform temporarily removed from 
the pool, was given to assess spatial memory in mice for the platform’s former location (in the 
sector III). The total time spent in the target sector III during the test were computed using a 
home-developed tracking system by using of a digital camera (Logitech QuickCam 3000, 
800x600 pixels, 15 fps) located 90 cm above the pool. 
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2.4 Histology/morphology and choline acetyltransferase (ChAT) evaluation 
 Immediately after memory test session, all mice were deeply anaesthetized with overdose of 
Nembutal (60 mg/kg, i.p., Sigma, USA), their brains were perfused through the left cardiac 
ventricle with a phosphate-buffered solution and verified on the extent of the bulbectomy. Only 
the brains with both bulbs fully removed (> 90% of their estimated volumes) and no damage to 
prefrontal cortices were accepted for further histological determination of a population ratio of 
pathological vs normal neurons and immunohistochemical analysis of the basal forebrain ChAT-
containing cells. The animals with insufficient bulbectomy were excluded from further analysis of 
results of their learning/memory abilities. 
 The brain blocks containing the cortex and hippocampus, preliminarily fixed in 4% 
paraformaldehyde (dissolved in 0.1 M PBS, pH 7.4) for 24 h at RT, were used for morphological 
and immunohistochemical evaluation. Each block was cut on a freezing microtome (Reicher, 
Austria) into 10-μm and 30-μm coronal sections collected at 70-μm intervals. The thin (10-μm) 
slices were stained with 0.1% Cresyl Violet, and their magnified (at 20x or 40x, optical 
microscope Nikon Eclipse E200) and digitized (DXM1200 camera) images were used for further 
morphological and morphometric examinations. All neurons were divided into a normal category 
and several pathologies characterized by cytolysis, karyolysis, pyknosis, and vacuolization. The 
neurons from different categories were counted in each investigated brain areas as a 
percentage of total cell population observed in 10-12 randomly selected fields (100 cells in each 
fields) in 3-4 sections per mouse. 
 The thick (30-μm) slices were used for the analysis of the ChAT-containing cells in the 
nucleus basalis magnocellularis (NBM) [27], the equivalent of the primate n. basalis of Meynert 
[28]. The slices were incubated in PBS with consecutive addition of a) 1% H2O2, for 30 min; b) 
5% bowing serum albumin, for 2 hours; c) polyclonal rabbit antibodies against ChAT (ab68799, 
Abcam, Cambridge, USA) with 1:200 dilution, for 12 hours at 4oC; d) biotinylated coat antibodies 
against rabbit's γ-globulines with 1:100 dilution, for 2 hours at 20oC; e) avidine-biotine complex 
with 1:100 dilution, for 1 hour at 20oC. The avidine-biotine complex's peroxidase activity was 
revealed by incubation of slices with both 0.5% 3,3'- diamino-benzidin-tetra-hydrochloride and 
0.02% H2O2 in PBS at 20oC. Finally, these slices were putted into the Apati's media followed by 
their examination at 40-x magnification on an optical microscope Nikon Eclipse E200 with digital 
DXM1200 camera. The images of slices with NMB were stored for further quantification of 
ChAT-immunopositive neurons. To evaluate the extent of the bulbectomy-produced damage in 
NBM a neuronal apoptosis was analyzed by use of two sorts of staining: conventional Nissl, for 
the whole cells, and DAPI, demonstrating nuclear chromatin destruction that is directly 
associated with apoptosis. In DADL analysis, only roundish intracellular nuclei with size of >10 
µm, typical for neurons, were used. The number of apoptotic neurons vs. total number of cells in 
3-4 brain slices with NBM was estimated and presented in percentage for each of the p75NTR 
fragments used.  
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2.5 Peptide Synthesis 
 Peptides were synthesized using reagents and amino acid derivatives produced by Merck 
(Germany) and Fluka (Switzerland). Immunological studies were carried out with the keyhole 
limpet hemocyanin (KLH) solution in PBS at a concentration of 5 mg/ml (Sigma–Aldrich, USA), 
25% aqueous solution of glutaric dialdehyde (Sigma, USA), Freund's complete adjuvant, 
Freund's incomplete adjuvant (Difco Laboratories, USA), goat antimouse immunoglobulin 
antibodies conjugated to horseradish peroxidase (Imtek, Russia), and 96-well Maxisorp plates 
(Nunc, Denmark). Peptides were chosen according to the sequence of the human p75 
(TNR16_HUMAN) UniProtKB), and their synthesis was carried out on Wang resin, using the 
Fmoc/But-scheme. All peptides contained additional C-terminal glycine residue. TBTU/ DIEA 
method was applied for elongation of peptide chain. Cleavage of peptides from the resin was 
carried out in a mixture of TFA (94%), triisopropylsilane (1%), 1,2-ethane dithiol (2.5%) , and 
water (2.5%) for 2 h. The peptides were purified by reverse phase HPLC in Phenomenex Jupiter 
10µ C18 300A 250× 10 mm in an acetonitrile gradient from 10 to 70% in 0.1% TFA solution. 
Synthetic peptides were characterized by the data of amino acid analysis, analytical HPLC, and 
mass spectrometry.  
 
2.6 Peptide conjugates with KLH and ovalbumin  
 The KLH-conjugated peptides were prepared as follows: 1 mg of the peptides was added to 
1 ml of KLH solution in PBS (5 mg/ml, pH 7.4) and stirred for 30 min. Then 50 µl of 0.25% 
glutaraldehyde solution was added by drops, incubated for 16 h, and dialyzed against PBS for 
18 h, with the buffer changed three times. The ovalbumin conjugate was prepared by dissolving 
1 mg of the peptide in 500 µl of PBS, with the addition of 2 mg of ovalbumin. Then 50 µl of 
hydrochloride N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide solution (0.08 mg/ml) was added 
by drops during 30 min, incubated under stirring (16 h) and dialyzed against PBS with the buffer 
changed two times.  
 
2.7 Statistics 
 Differences in behavioral, immunohistochemical and morphometric parameters were 
evaluated by either non-parametric Mann-Whitney U-test, one/two-way ANOVA for repeated 
measures or two-tailed Student’s t-test, when appropriate (p < 0.05 was deemed statistically 
significant). The data in the text and figures are expressed as mean ± SEM. 
 
3. Results 
 
3.1 Selective effects of immunization against different p75NTR fragments on acetylcholine-
synthesized capability of neurons in the nucleus basalis magnocellularis (n. Meynert) 
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 To test the idea of possible brain protection against amyloid-produced toxicity by use of an 
immunological blockade of Aβ binding with the neurotrophin receptors we have studied 
forebrain cholinergic neuron functioning in the olfactory-bulbectomized (OBX) mice, which have 
been shown to be characterized by enhanced Aβ levels in the brain [29]. In this section, there 
were analyzed 498 brain slices from 48 mice distributed within the groups as follows 
(slices/mice): SO (61/7), OBX (86/6) or OBX after the immunization with synthetic peptides, the 
analogs of the p75NTR fragments. They were the following (slices/mice): 32-46 (94/6), 39-47 
(25/3), 66-72 (24/3), 86-93 (46/4), 97-105 (44/4), 115-122 (27/3), 147-154 (35/4), 155-164 
(24/4), and 167-176 (32/4). In the immunohistochemical staining of the brain slices by use of 
specific antibodies against choline acetyltransferase (ChAT), a key enzyme for acetylcholine 
synthesis, significant depletion of the neuronal population of the forebrain ChAT-positive 
neurons in NBM was revealed in OBX- vs. SO-mice one month after the bulbectomy (Fig. 1, A). 
After the immunization with synthetic analogs of the p75NTR fragments, only four of them with 
residuals of 32-46, 86-93, 155-164, and 167-176 were statistically effective in protecting the 
cholinergic cells from their depletion observed in non-immunized OBX-mice, with maximal 
effects associated with peptides of 155-164 and 167-176 (Fig. 1, A). This is clearly visible on 
individual slices with enhanced densities of ChAT-containing neurons in NBM in two OBX-mice, 
immunized against 155-164 and 167-176 fragments of p75NTR (c.f., Fig. 1, E and F vs. D, 
respectively) and confirmed by one-way ANOVA (F10,487 = 74.6, p < 0.001) for the whole set of 
slices.  
 In NBM area, increased amount of apoptotic cells was found (Fig. 2) in brain slices from 
OBX- vs. SO-mice (n= 136/25 vs. 18/7, respectively) that was significant regardless whether the 
data from all OBX-mice or only from treated with p75NTR fragments were used (one-way 
ANOVA: F10,143 = 12.2 or F9,132 = 10.8, respectively, p < 0.001, for both). However, the 
immunized vs. non-immunized OBX-mice demonstrated significant shrinking of apoptotic cell 
populations (one-way ANOVA: F9,126 = 7.9, p < 0.001) with evident beneficial effect for p75NTR 
fragments of 39-47, 66-72, 97-105, 155-164, and 167-176 (16/3, 16/3, 16/3, 12/3, and 12/3 
slices/mice, respectively). In contrast to these, the treatments with 32-46, 86-93, 115-122, and 
147-154 (16/4, 12/3, 8/2, and 16/3 slices/mice, respectively) were practically ineffective.
 Whether such immunization is beneficial for other brain structures, affected by bulbectomy, is 
analyzed in the next section. 
 
3.2. Morphological and functional characteristics of cortical and hippocampal neurons after 
immunization against different p75NTR fragments  
 Recently, in OBX-mice, demonstrating typical AD hallmarks, pathological changes in the 
cortical and hippocampal neurons, closely associated with learning and memory processing, 
have been revealed [26]. The development of these cellular changes was characterized by 
either nuclear fading (karyolysis) or shrinkage (pyknosis), membrane disintegration (cytolysis), 
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intracellular vacuole formation (vacuolization), and by decreased neuronal density, resulting in 
neuronal death (Fig. 3, A). Statistical analysis of these parameters in OBX-mice has revealed a 
predominantly protective influence of the immunization against the p75NTR fragments on the 
survival of cortical and hippocampal neurons (Fig. 3, B). This immunological approach 
significantly improved their morphological and functional characteristics, i.e., increased the 
number of healthy neurons (Fig. 3, B, a) at the expense of those with cytolysis, karyolysis, and 
pyknosis (Fig. 3, B, b, d, and e, respectively). The beneficial effect of the immunization against 
p75NTR fragment of 167-176, expressed in the neuronal density (Fig. 3, B, f), in particular, was 
evident in OBX- vs. SO-mice (c.f., Fig. 3, B, f vs. С, f, sector 9, both). In contrast, enlarged 
population of the vacuolated neurons (Fig. 3, B, c) and decreased neuronal density in OBX-
mice treated with 32-46, 115-122, and 147-154 p75NTR fragments (Fig. 3, B, f, sectors 1, 6, 
and 7, respectively) was observed. Thus, protective effects of the immunization against p75NTR 
fragments in OBX-mice were expressed to a variable extent depending on the specificity of the 
fragments; however, a common non-specific tendency for some morphological characteristics 
was revealed as well. To define this more exactly an additional series of experiments on 49 SO-
mice was performed with immunization against most of the p75 NTR fragments used on OBX-
mice: 39-47; 86-93; 97-105; 147-154; 155-164, and 167-176. With the exception of 167-176 
p75NTR fragment (Fig. 3, C, sector 9), the immunization against other fragments negatively 
affected the neuronal morphology in SO-mice, supporting the conclusion that this treatment 
specifically protects OBX-damaged brains from the pathology seemingly associated with 
enhanced Aβ level. Maximal negative changes in SO-mice were observed after the 
immunization against 86-93 and 147-154 p75NTR fragments (Fig. 3, C, sectors 4 and 7, 
respectively) and were expressed in both decreased population of healthy neurons (Fig. 3, C, a) 
and increased ones of pathological cells with visible cytolysis, vacuolization, and karyolysis (Fig. 
3, C, b-d). The changes in CA3 are especially impressive as they observed at relatively low 
reference level of neuronal density in this area (Fig. 3, A, f). The immunological treatment with 
155-164 p75NTR fragment resulted in shrinkage of the karyolitic cell population both in the 
cortex and hippocampus (Fig. 3, C, d, sector 8), whereas the populations of cells with other 
pathological features were increased exclusively in the cortex (Fig. 3, C, b, c, e). Interestingly, 
the beneficial influence of the immunization against 167-176 p75NTR fragment on neuronal 
morphology in OBX-mice were observed, to a lesser extent, in SO-mice as well (c.f., Fig. 3, B 
and C, a, b, d, sector 9). (For simplicity, the data associated with figure 3 has been included in 
Supplemental materials.)  
 Whether the beneficial effects of the immunization on neuronal morphology is correlated with 
spatial memory improvement, as tested in Morris water maze, will be analyzed in the next 
section. 
 
3.3. Effects of the immunization against p75NTR fragments on spatial memory 
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 In the beginning of the main experiments, individual swimming capabilities of mice were 
evaluated in the water pool. Mean latencies to reach the visible platform for OBX- and SO-mice 
(n = 82 and 49, respectively) were approximately equal (7.3 ± 0.4 s and 8.1 ± 0.6 s, 
respectively; t-test, p > 0.05) regardless of whether they were immunized or not. In the following 
training days with the hidden platform, significant decrease of latencies in the 4th vs. the 1st 
session was observed in both OBX- and SO-mice (Fig. 4, A and 5, A, two-way ANOVA: F1,140 = 
104 and F1,74 = 71, respectively, p = < 0.001, for both). Thus, the animals from each group have 
been learned to reach the platform with reasonably latencies. OBX-mice were distributed within 
the groups as follows (the number of mice): without (16) and after the immunization with 
synthetic peptides, the analogs of the p75NTR fragments of 32-46 (5), 39-47 (6), 66-72 (7), 86-
93 (6), 97-105 (7), 115-122 (6), 147-154 (4), 155-164 (7), 167-176 (7), KLH (6), and VP1 (5). 
SO-mice did the same as follows: without the immunization (15) and after the immunization with 
the p75NTR fragments of 39-47 (5), 86-93 (3), 97-105 (5), 147-154 (3), 155-164 (4), 167-176 
(5), KLH (5), and VP1 (4). 
 The memory testing revealed that the trained OBX-mice from all groups spent significantly 
less time in the target sector III than SO-mice (one-way ANOVA: F12,83 = 8.9, p < 0.001), 
however, OBX-mice immunized against 32-46, 155-164, and 167-176 p75NTR fragments 
demonstrated partial memory improvement vs. non-immunized OBX-animals (Fig. 4, B). The 
immunization against these fragments has been shown above to be responsible for the 
beneficial effect on the functioning of acetylcholine-synthesized neurons in the basal forebrain 
(see Fig. 1, A). Furthermore, the treatment with 155-164 and 167-176 p75NTR fragments 
evidently rescued morphology of cortical and hippocampal neurons (see Fig. 3, a, b, d, e, 
sectors 8 and 9). In contrast, spatial memory in SO-mice was insensitive (one-way ANOVA: F7,37 
= 1.9, p > 0.05) to the immunization against those fragments which were effective for OBX-mice 
(c.f., Figs. 4, B and 5, B). Moreover, the treatment with 86-93 and 147-154 p75NTR fragments 
tended to impair the memory in SO-mice, and this was well correlated with the negative effects 
on neuronal morphology in the cortex and hippocampus (see Fig. 3, C, a - d, sectors 4 and 7). 
 Therefore, it is reasonable to conclude that, in OBX- vs. SO-mice, identical p75NTR 
fragments are differently involved in different ways in memory functioning and neuronal 
organization in the brain. The only exception is associated with 167-176 fragment whose 
immunological blockade produced the cholinergic and morphological protective effects both in 
OBX- and, partially, in SO-mice. 
 
4. Discussion 
 
 In this study, the effects of the immunization against several selected p75NTR fragments in 
OBX-mice, characterized by typical hallmarks of Alzheimer’s type neurodegeneration, were 
analyzed to reveal the most effective path to develop a new perspective approach for AD 
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treatment. We suggest that the observed effects of the immunization were predominantly 
initiated by a blockade of the fragment-associated binding sites in the extracellular domain of 
p75NTR by appropriate antibodies whose titers were sufficiently high in our study (Table 1). 
 The immunization against some of p75NTR fragments in OBX-mice improved their spatial 
memory, lowered cholinergic deficit and number of neurons with apoptosis in the basal 
forebrain, and normalized cellular morphology in the cortex and hippocampus. Maximal positive 
effects were observed after the immunization against 155-164 and 167-176 amino acid residues 
of p75NTR. One negative consequence of this treatment became apparent in the decrease of 
neuronal density, especially, in the hippocampus (Fig. 3, B, f) that seemingly was associated 
with disturbances in the apoptotic or, alternatively, autophagy mechanism, noticed at the AD 
progression [30]. The increased density of ChAT-immunopositive neurons in the forebrain 
observed in our study after immunization against some p75NTR fragments (Fig. 1, A) is in line 
with evidence both of enhanced cholinergic innervations in the cortex and hippocampus in 
knock-out-mice (ChAT-cre p75(in/in) lacking p75NTR [31] and increased numbers of such 
neurons [32]. In general, our results are in line with evidence of the critical role of p75NTR in the 
degeneration of cholinergic neurons evoked by exposure either to Aβ [18], [13] or to pro-
/neurotrophins [33]. Indeed, the antibodies against the extracellular p75NTR have been shown 
to inhibit Aβ-induced cell death and significantly diminished cell loss [20]. Furthermore, the 
immunization against some p75NTR fragments in OBX-mice was accompanied in our study by 
diminished numbers of apoptotic neurons in the cholinergic areas of their forebrains (Fig. 2). 
Moreover, enhanced expression of both p75NTR, its major ligand, pro-neurotrophin, and Aβ, in 
AD brains [34], [15] suggest that antibodies against binding sites for the ligands, inducing 
apoptotic processes, will be able to improve memory in OBX-mice and neuronal morphology in 
their brains.  
 We have revealed that the most protective effect in OBX-mice was produced by the 
immunological blockade of 155-164 and 167-176 fragments of p75NTR. However, in spite of 
practically identical roles of these amino acid residues for survival/death of ChAT-containing 
neurons (Fig. 1, A), the protective effects of their blockade may originate from different sources. 
We have shown recently that the immunological blockade of 155-164 residues in p75NTR of 
OBX-mice, characterized by enhanced level of Aβ [29], was accompanied by significant 
decrease of the brain Aβ level, whereas immunization against the 167-176 residue was 
ineffective [35]. Thus, the 155-164 fragment of the p75NTR extracellular domain may 
specifically be involved in the mechanisms of either Aβ binding with p75NTR or Aβ aggregation 
[36], or, alternatively, in guiding Aβ to lysosomes for consecutive degradation in cholinergic 
neurons [11]. Regardless of the mechanisms associated with the lowering of Aβ in the brain, the 
immunological blockade of the 155-164 residue may be useful approach for the brain protection 
from AD-linked cholinergic deficit and memory impairment, in particular, by the improving of the 
memory consolidation provided by synapse remodeling [37].  
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 In summary, in spite of some differences in the effects of the immunization against various 
p75NTR fragments in OBX-mice, evident similarities were observed in morphological 
characteristics of cortical and hippocampal neurons (Fig. 3, B), that might be considered as a 
non-specific action of the active immunization. However, this approach applied to SO-mice 
showed either no or opposite effects. This suggests that the pathological/neurodegenerative 
processes in OBX-mice are accompanied by changes in the role of the studied fragments of 
p75NTR extracellular domain in cell survival. Thus, the immunological blockade of p75NTR 155-
164 fragment exerts either a negligible or negative influence on neuronal characteristics in SO-
mice, whereas improvements of both memory and neuronal morphology, including increased 
number of acetylcholine-producing cells, in the forebrain were evident. In contrast, the treatment 
with 86-93 and 147-154 p75NTR fragments impaired the memory and neuronal characteristics 
in SO-mice without significant negative influences on OBX-mice. Interestingly, the immunization 
against p75NTR 167-176 fragment was accompanied by positive effects in both OBX- and SO-
mice. The structural basis for these may include various conformational transformations after 
the blockade of neurotrophin or proneurotrophin binding to р75NTR. In this case, conformational 
mechanisms apparently have to be sensitive to the extracellular domain structures of the 
receptor. It is well known that dimeric р75NTR is able to bind to NT-4 receptor with low affinity 
and to stimulate neurogenesis. Moreover, p75NTR, in conjunction with dimeric TrkA, TrkB, and 
TrkС receptors, has shown to enhance efficacy of their binding with neurotrophic factors such 
as NGF, BDNF, NT-3, and NT-4 [38] to enhance, in turn, the survival rate of cells.  
 In conclusion, a study of interactive functioning of p75NTR and Trk receptors by using of 
immunological means may be a key approach for both the understanding of mechanisms of 
neuronal degeneration and the developing of effective new treatment applicable for AD [13], 
aging [39] and other neurodegenerative diseases associated with cholinergic system 
malfunctioning in the brain. 
 
5. Conclusion 
 In the olfactory bulbectomized rats with typical hallmarks of Alzheimer disease type of 
degeneration, we have demonstrated protective effects of the immunization against two of nine 
specific fragments of p75 neurotrophin receptor extracellular domain on both cholinergic 
neurons in the forebrain and cognitive abilities in the animals.  
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 Table 1. Serum antibody titers in the olfactory-bulbectomized mice immunized against 
different synthetic p75 fragments conjugated with the KLH-peptide. 
 
 Serum antibody titers (in -lg of sera dilution) vs. p75NTR fragments 
P75NTR 
fragment 
32-
46 
39-
47 
66-
72 
86-
93 
97-
105 
115-
122 
147-
154 
155-
164 
167-
176 
Antibody 
titer 
3.8-
4.1 
3.4-
4.1 
3.1-
3.4 
3.1-
3.4 
3.7-
4.1 
2.2-
2.8 
2.2-
2.5 
3.1-
3.8 
3.4-
4.1 
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Figure legends 
 
Figure 1. Detrimental effect of the olfactory bulbectomy (OBX) in mice on the density of choline 
acetyltransferase (ChAT)-containing neurons in the forebrain, beneficial effects of the 
immunization against the p75NTR amino acid residues of 32-46, 86-93, and147-154, and 
overgrowing effects of the treatment with 155-164 and 167-176 fragments. The immunoreactive 
labeling against ChAT in the nucleus basalis magnocellularis on the representative examples 
(taken from the area marked by a rectangle on B) demonstrates decreased number of the 
labeled cells after the bulbectomy (c.f., C and D) and their recovery after the immunization 
against the fragments of 155-164 (E) and 167-176 (F). White horizontal bars on C - F plates are 
the scale bars of 50 μm. On A, error bars show 1 SEM; star or plus denote significant 
differences vs. either SO or OBX, respectively (one and two markers are p<0.05 and 0.01, 
Mann-Whitney U-test). The brain slice on B was modified from [40]. 
 
Figure 2. Increase of the apoptotic cell population in the nucleus basalis magnocellularis in 
OBX- vs. SO-mice (OBX+V vs. SO+V) and neuronal protective effect of the immunization 
against p75NTR fragments of 39-47, 66-72, 97-105, 155-164, and 167-176. Stars denote 
significant (p < 0.01, Mann-Whitney U-test) differences vs. OBX. Error bars show 1 SEM. 
 
Figure 3. Morphological and functional characteristics of neurons in the temporal cortex and in 
the hippocampal areas of CA1 and CA3 after immunization against different p75NTR fragments. 
On A: statistical characterization of non-immunized SO-and OBX-mice, where stars denote 
significant (p < 0.01, Mann-Whitney U-test) difference between them; on B: radial presentation 
of the effects produced by the immunization against each of studied fragments of p75NTR in 
OBX-mice; on C: the same in SO-mice. A description to the radial diagrams is shown on I. 
(Supporting experimental data in numerical format is presented in Tables 2 and 3 in 
Supplementary Materials). 
 
Figure 4. Learning (A) and memory (B) abilities of OBX-mice immunized against different 
fragments of p75NTR. On A, decreased latency in reaching the saving platform on the 4th day 
(gray bars) vs. that on the 1st day (white bars) of learning is shown. Stars denote significant 
latency differences between the days: one and two markers are p < 0.05 and 0.01, respectively 
(Mann-Whitney U-test). On B, in session with memory testing, relative (vs. "SO+V" control) time 
spending in the sector where the saving platform was placed during learning was decreased in 
OBX-mice, with exception of partial recovery for those immunized against p75NTR fragments of 
32-46, 155-164, and 167-176. Stars and pluses denote significant differences (one and two 
markers are p <0.05 and 0.01, respectively, Mann-Whitney U-test) vs. SO and OBX, 
respectively. On both plates: V, KLH, and VP1 denote Vehicle, Keyhole Limpet Hemocyanin 
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conjugate, and a protein from foot-and-mouth disease virus, respectively; error bars show 1 
SEM. 
 
Figure 5. Learning (A) and memory (B) abilities of SO-mice immunized against different 
fragments of p75NTR. On A, decreased latency in reaching the saving platform on the 4th day 
(gray bars) vs. that on the 1st day (white bars) of learning is shown. Stars denote significant (p < 
0.01, Mann-Whitney U-test) latency differences between the days. On B, in session with 
memory testing, relative (vs. "Vehicle" control) time spending in the target sector was 
comparable in all groups of mice. On both plates: KLH denotes Keyhole Limpet Hemocyanin 
conjugate; error bars show 1 SEM. 
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Supplemental Materials 
Table 2 (supplemental). Morphological and functional characteristics of neurons in the 
temporal cortex and in the hippocampal areas of CA1-CA2 and CA3-CA4 in olfactory-
bulbectomized (OBX) mice after immunization against different p75NTR fragments. 
 
 Group 
Of mice 
Neuronal 
density 
(n/mm2) 
Normal 
neurons 
(%) 
Pathological neurons (%) 
Pyknosis Cytolysis Karyolysis 
Vacuoli-
zation 
T
e
m
p
o
ra
l 
c
o
rt
e
x
 
SO 
OBX 
(32-46) 
(39-47) 
(66-72) 
(86-93) 
(97-105) 
(115-122) 
(147-154) 
(155-164) 
(167-176) 
1200±15,7** 
1110±16,1 
883±12,8** 
1122±7,9 
1099±8,3 
971±12,9** 
1123±8,7 
1049±18,4* 
950±24,4** 
1113±8,9 
1298±9,1** 
79,1±0,80** 
50,4±0,73 
63,6±0,39 
69,6±0,96** 
73,5±0,40** 
65,9±0,44** 
75,0±0,62** 
67,7±0,89** 
71,6±1,05** 
69,9±0,69** 
74,0±1,38** 
3,1±0.26** 
14,1±0,34 
4,4±0.25** 
4,1±0.23** 
2.4±0.18** 
2,4±0,21** 
3,8±0,34** 
3,8±0,31** 
2,4±0,49** 
5,6±0,31** 
4,2±0.26** 
10,9±0,43** 
24,3±0,57 
20,9±0,25** 
13,7±0,49** 
15,3±0,44** 
19,9±0,27** 
13,1±0,33** 
18,3±0,47** 
18,4±0,58** 
14,6±0,39** 
11,7±0,63** 
4,4±0,21** 
7,3±0,21 
5,4±0,23** 
4,4±0,23** 
5,1±0,19** 
6,5±0,19 
4,1±0,21** 
6,1±0,34* 
4,8±0,42** 
5,5±0,25** 
4,5±0,27** 
1,7±0,15** 
3,9±0,3 
5,7±0,23** 
8,1±0,59** 
3,7±0,21 
5,2±0,23** 
3,9±0,29 
4,2±0,29 
2,8±0,33* 
4,7±0,22* 
5,6±0,61* 
С
А
1
-С
А
2
 (
H
ip
p
o
c
a
m
p
u
s
) 
SO 
OBX 
(32-46) 
(39-47) 
(66-72) 
(86-93) 
(97-105) 
(115-122) 
(147-154) 
(155-164) 
(167-176) 
2782±21,1* 
2749±22,3 
2693±13,9 
2741±18,4 
2783±14,3 
2664±13,3** 
2781±11,7 
2652±17,5* 
2656±32,4* 
2745±14,6 
2814±18,8* 
83,6±0,68** 
58,9±0,79 
73,2±0,47** 
74,4±0,70** 
80,5±0,46** 
69,8±0,46** 
80,9±0,91** 
70,2±0,55** 
75,8±1,08** 
75,8±1,02** 
73,9±0,65** 
2,2±0.22** 
10,3±0,41 
1,3±0,13** 
2,6±0,25** 
1,0±0,13** 
1,1±0,15** 
2,4±0,31** 
2,1±0,31** 
0,9±0,35** 
3,6±0,27** 
3,6±0,24** 
9,6±0.43** 
21,4±0,42 
16,2±0,31** 
13,7±0,36** 
12,4±0,28** 
19,3±0,27** 
10,7±0,43** 
17,6±0,27** 
11,6±0,81** 
13,0±0,51** 
12,8±0,32** 
3,5±0,29** 
6,3±0,37 
5,8±0,33 
3,2±0,21** 
3,8±0,21** 
4,4±0,22** 
3,2±0,25* 
6,3±0,26 
6,3±0,37 
4,6±0,22** 
5,6±0,27 
1,2±0,17** 
3,1±0,24 
3,6±0,19 
6,1±0,52** 
2,2±0,21* 
5,8±0,21** 
2,8±0,27 
3,7±0,24 
5,4±0,56* 
3,4±0,41 
4,0±0,45 
С
А
3
-С
А
4
 (
H
ip
p
o
c
a
m
p
u
s
) 
SO 
OBX 
(32-46) 
(39-47) 
(66-72) 
(86-93) 
(97-105) 
(115-122) 
(147-154) 
(155-164) 
(167-176) 
2123±20,5 
2066 ± 21,1 
2037±11,2 
2008±14,1* 
2045±9,7 
2089±11,3 
2006±11,2* 
2011±12,9* 
2042±34,5 
2053±14,2 
2119±10,3* 
82,1±0,63** 
56,5±1,00 
68,5±0,82** 
75,4±0,73** 
79,2±0,53** 
66,6±0,37** 
78,1±0,74** 
69,1±1,80** 
77,6±0,92** 
78,1±1,01** 
77,3±1,26** 
2,1±0.23** 
10,2±0,46 
1,4±0,16** 
3,9±0,37** 
1,1±0,13** 
0,9±0,12** 
2,9±0,26** 
1,5±0,19** 
1,3±0,37** 
3,4±0,24** 
2,8±0,23** 
10,3±0,44** 
23,5±0,62 
18,3±0,45** 
11,1±0,42** 
13,0±0,30** 
20,4±0,25** 
11,9±0,44** 
16,1±0,43** 
12,2±0,51** 
12,4±0,58** 
10,8±0,70** 
3,9±0,24** 
7,4±0,32 
6,1±0,27* 
3,5±0,24** 
3,3±0,19** 
6,6±0,22 
3,5±0,21** 
5,9±0,22** 
4,4±0,37** 
3,4±0,31** 
4,3±0,27** 
1,6±0,19* 
2,3±0,21 
5,9±0,28** 
6,0±0,32** 
3,4±0,21** 
5,6±0,21** 
3,4±0,21* 
6,0±0,25** 
4,5±0,43** 
2,8±0,23 
4,8±0,43** 
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Notes: Statistical characterization (mean ± SEM) of OBX-mice immunized against 
p75NTR fragments (shown in brackets), where stars denote significant (* - p < 0.05; ** - 
р < 0.01, Mann-Whitney U-test) difference vs. "OBX" (underlined) group.  
 
 
 
Table 3 (supplemental). Morphological and functional characteristics of neurons in the 
temporal cortex and in the hippocampal areas of CA1-CA2 and CA3-CA4 in sham-
operated (SO) mice after immunization against different p75NTR fragments. 
 
 Group 
of mice 
Neuronal 
density 
(n/mm2) 
Normal 
neurons 
(%) 
Pathological neurons (%) 
Pyknosis Cytolysis Karyolysis 
Vacuoli-
zation 
T
e
m
p
o
ra
l 
c
o
rt
e
x
 
Vehicle 
(39-47) 
(86-93) 
(97-105) 
(147-154) 
(155-164) 
(167-176) 
1200±15.7 
1193±12.8 
1181±13.7 
1179±10.9 
1175±12.8 
1181±13.9 
1198±15.0 
79.1±0.80 
74.2±0.48** 
68.8±0.52** 
73.5±0.40** 
71.1±0.33** 
73.9±0.47** 
79.2±0.86 
3.1±0.26 
2.8±0.25 
1.0±0.19** 
2.7±0.25 
2.7±0.18 
4.2±0.24* 
3.8±0.28 
10.9±0.44 
13.8±0.28** 
15.9±0.36** 
13.4±0.31** 
14.3±0.22** 
14.3±0.25** 
10.3±0.46 
4.4±0.21 
4.5±0.2 
8.1±0.28** 
5.0±0.19 
6.2±0.22** 
3.5±0.20* 
3.5±0.20* 
1.7±0.2  
4.6±0.27** 
6.3±0.25** 
5.5±0.23** 
5.6±0.25** 
4.0±0.24** 
3.3±0.27** 
С
А
1
-С
А
2
 (
H
ip
p
) 
Vehicle 
(39-47) 
(86-93) 
(97-105) 
(147-154) 
(155-164) 
(167-176) 
2782±21.1 
2737±14.4 
2843±20.2* 
2828±16.3 
2762±11.7 
2753±15.3 
2819±18.8 
83.6±0.68 
75.5±0.69** 
74.1±0.87** 
75.0±0.60** 
69.3±0.40** 
84.1±0.44 
89.5±0.49** 
2.2±0.25 
2.6±0.29 
1.0±0.22** 
1.7±0.17 
1.7±0.25 
2.3±0.21 
1.9±0.21 
9.6±0.43 
13.9±0.39** 
14.7±0.54** 
13.9±0.36** 
16.0±0.34** 
10.5±0.32 
4.6±0.20** 
3.5±0.29 
2.6±0.29 
5.8±0.45** 
4.1±0.28 
8.0±0.24** 
2.1±0.21* 
2.4±0.22* 
1.2±0.17 
4.7±0.23** 
4.4±0.25** 
5.4±0.21** 
5.0±0.28** 
1.8±0.19 
1.7±0.18 
С
А
3
-С
А
4
 (
H
ip
p
) 
Vehicle 
(39-47) 
(86-93) 
(97-105) 
(147-154) 
(155-164) 
(167-176) 
2123±20.45 
2118 ± 8.6 
2028±17.9** 
2091±12.9 
2002±11.6** 
2042±14.5* 
2131±13.0 
82.1±0.63 
76.5±0.39** 
67.2±0.58** 
77.4±0.50** 
66.7±0.51** 
82.5±0.40 
90.7±0.43** 
2.1±0.24 
3.1±0.24* 
1.1±0.24* 
1.6±0.17 
2.2±0.21 
2.8±0.20 
1.9±0.17 
10.3±0.44 
13.9±0.29** 
16.7±0.31** 
13.0±0.28** 
16.8±0.3** 
11.9±0.3* 
4.4±0.28** 
3.9±0.40 
2.7±0.29* 
5.3±0.98 
4.0±0.19 
9.4±0.22** 
2.1±0.35** 
2.1±0.20** 
1.6±0.19 
3.6±0.19** 
5.6±0.32** 
3.9±0.23** 
4.8±0.33** 
2.5±0.22* 
1.2±0.15 
 
Notes: Statistical characterization (mean ± SEM) of SO-mice immunized against 
p75NTR fragments (shown in brackets), where stars denote significant (* - p < 0.05; ** - 
р < 0.01, Mann-Whitney U-test) difference vs. the "Vehicle" (underlined) group. The 
hippocampus is abbreviated as Hipp.  
 
